Ethambutol/isoniazid
Ethambutol/isoniazid is a medication used to treat tuberculosis.[1] It is a fixed dose combination of ethambutol and isoniazid.[1] It is used along with other antituberculosis medication.[1] It is taken by mouth.[1]
| Combination of | |
|---|---|
| Ethambutol | Anti-tuberculosis medication |
| Isoniazid | Anti-tuberculosis medication |
| Clinical data | |
| Pregnancy category |
|
| ATC code | |
Side effects are those of the underlying medications.[1] More common side effects include poor coordination, numbness, and liver problems.[2] Liver problems may be severe and are more likely in people over the age of 50.[2] Use is not recommended in children.[1] It is unclear if use in pregnancy is safe for the baby.[2]
It was removed from the World Health Organization's List of Essential Medicines in 2019.[3] The wholesale cost in the developing world is about 1.47 to 1.99 USD a month.[4] The combination product is not available in Canada or in the United States.[2]
References
- WHO Model Formulary 2008 (PDF). World Health Organization. 2009. p. 140. ISBN 9789241547659. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016.
- "Ethambutol and Isoniazid Drug Information, Professional". www.drugs.com. November 1998. Archived from the original on 21 December 2016. Retrieved 18 December 2016.
- "Executive summary: the selection and use of essential medicines 2019: report of the 22nd WHO Expert Committee on the selection and use of essential medicines: WHO Headquarters, Geneva, 1-5 April 2019". 2019. hdl:10665/325773. Cite journal requires
|journal=(help) - "Ethambutol + Isoniazid". International Drug Price Indicator Guide. Retrieved 8 December 2016.